Clinical Trial Update: Efficacy and Safety of Bempedoic Acid in Association With Anti-PCSK9 and Ezetimibe in Statin-intolerant Patients [Phase 4]

View source ↗

Summary

Phase 4 trial assessing efficacy and safety of bempedoic acid combined with anti-PCSK9 therapy and ezetimibe in statin-intolerant patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Dyslipidemias
• Lipid Metabolism Disorders

Drugs mentioned

• Bempedoic Acid (bempedoic acid)
• EZETIMIBE (EZETIMIBE)
• anti-PCSK9 therapy

Snippet

Sponsor: University of Salerno | Conditions: Dyslipidemias, Statin Adverse Reaction | Phase 4 | Status: NOT_YET_RECRUITING